1-2 of 2
Authors: James F Cummings
Journal Article
594. A Phase I, Multicenter, Randomized, Double-blind, Placebo-controlled Single Dose, Dose-ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of Orally Administered Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females ≥ 18 years Old and Their Breast-feeding Infants Open Access
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.189, https://doi.org/10.1093/ofid/ofae631.189
Published: 29 January 2025
Journal Article
220. A Phase 2 Double-Blind, Placebo-Controlled Study Showing Oral Tableted Norovirus Vaccine VXA-G1.1-NN is Immunogenic, Efficacious, and Reduces Viral Shedding Following Norovirus Challenge Open Access
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.078, https://doi.org/10.1093/ofid/ofae631.078
Published: 29 January 2025
